Moreover, although data comparing levels of glycosylation between different arthritides are not available, it has been shown that effective treatment with TNF inhibitors increased IgG glycosylation levels in both RA and spondylarthritis [37]. The gene discussed is TNF; the disease is rheumatoid arthritis.